Correlation Between NovaBay Pharmaceuticals and Virios Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NovaBay Pharmaceuticals and Virios Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NovaBay Pharmaceuticals and Virios Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NovaBay Pharmaceuticals and Virios Therapeutics Llc, you can compare the effects of market volatilities on NovaBay Pharmaceuticals and Virios Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NovaBay Pharmaceuticals with a short position of Virios Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NovaBay Pharmaceuticals and Virios Therapeutics.

Diversification Opportunities for NovaBay Pharmaceuticals and Virios Therapeutics

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between NovaBay and Virios is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding NovaBay Pharmaceuticals and Virios Therapeutics Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virios Therapeutics Llc and NovaBay Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NovaBay Pharmaceuticals are associated (or correlated) with Virios Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virios Therapeutics Llc has no effect on the direction of NovaBay Pharmaceuticals i.e., NovaBay Pharmaceuticals and Virios Therapeutics go up and down completely randomly.

Pair Corralation between NovaBay Pharmaceuticals and Virios Therapeutics

If you would invest  55.00  in NovaBay Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  7.00  from holding NovaBay Pharmaceuticals or generate 12.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy4.76%
ValuesDaily Returns

NovaBay Pharmaceuticals  vs.  Virios Therapeutics Llc

 Performance 
       Timeline  
NovaBay Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NovaBay Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, NovaBay Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Virios Therapeutics Llc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virios Therapeutics Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Virios Therapeutics is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

NovaBay Pharmaceuticals and Virios Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NovaBay Pharmaceuticals and Virios Therapeutics

The main advantage of trading using opposite NovaBay Pharmaceuticals and Virios Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NovaBay Pharmaceuticals position performs unexpectedly, Virios Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virios Therapeutics will offset losses from the drop in Virios Therapeutics' long position.
The idea behind NovaBay Pharmaceuticals and Virios Therapeutics Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamental Analysis
View fundamental data based on most recent published financial statements
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments